NYSE:ORCL

Oracle (ORCL)

127.94
-3.60 (2.74%)
as of Jul 14, 2026, 8:00:00 pm Market Open.
302 watching
0
Investor Insights
star iconJul 14, 2026, 12:00 am

This summary was created by AI, based on 45 opinions in the last 12 months.

Oracle Corporation is currently experiencing a challenging period, marked by a significant drop in stock performance and rising concerns over its high levels of debt. Recent reviews highlight the company's aggressive investments in AI and data centers, which could either lead to substantial long-term gains or exacerbate its financial struggles if not managed well. While some analysts express optimism about Oracle’s future profitability, particularly with potential earnings doubling by 2030, others caution that the high capital expenditure and debt load may hinder growth. Amidst this mixed sentiment, the company's upcoming earnings report is viewed with interest, as analysts seek clarity on its operational plans and financial health, given the uncertainty surrounding its cash flow and debt servicing capabilities.

consensus icon
Consensus
Mixed
valuation icon
Valuation
Overvalued
review icon
Similar
IBM
DON'T BUY
High P/E. Quality company. Watching. Near term NO.
PAST TOP PICK
(Was a top pick on May 4/01 up 1%) Well positioned. New products.
DON'T BUY
So-so rating. Will continue to struggle.
BUY
Is buying. Good new product line. Strong mngmnt.
BUY
Have a good grip on their sector. Can grow $20 over next 5/10 years.
DON'T BUY
New product revisions which will help. Needs to work on the application side.
BUY
A main stay in the techs. Good position.
WAIT
Fundamentals in software are still are still weak. Wait for their report on June18.
BUY
Volatile. Great potential over the long term.
TOP PICK
Under $15 is a good buy. Worries about mngmnt.
WAIT
Pretty rich now. Wait until after the quarter figures.
DON'T BUY
Better stocks are available. Would buy at $15/16.
BUY
Best opportunity in B to B for continued growth.
TOP PICK
Short term will have a little weakness. Long term good. Excellent product.
DON'T BUY
Fairly expensive. No visibility of earnings.
Showing 346 to 360 of 377 entries